FDA Issues Warning of Guillain-Barre Syndrome Risk for 2 RSV Vaccines. Anderer S. JAMA 2025 Feb 21. doi: 10.1001/jama.2025.0545.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anderer S. FDA Issues Warning of Guillain-Barre Syndrome Risk for 2 RSV Vaccines. JAMA 2025 Feb 21. doi: 10.1001/jama.2025.0545.
PMID: 39982701